Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma

The goal of the research was to assess the quantitative relationship between median progression-free survival (PFS) and median overall survival (OS) specifically among patients with relapsed/refractory multipl...

Source: BMC Cancer - April 29, 2024 Category: Cancer & Oncology Authors: Meletios Dimopoulos, Pieter Sonneveld, Salomon Manier, Annette Lam, Tito Roccia, Jordan M. Schecter, Patricia Cost, Lida Pacaud, Abbey Poirier, Gabriel Tremblay, Tommy Lan, Satish Valluri and Shaji Kumar Tags: Research Source Type: research